Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem PK in Post-Neurosurgical CNS Infection
NCT02506686Phase 4Completed
- Sponsor
- Huashan Hospital
- Start
- Sep 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of meropenem in Central nervous system infection and meningitis, sponsored by Huashan Hospital. Primary endpoint: Concentrations of meropenem in plasma and CSF up to 12 months. Started Sep 2008; status: completed.
02
Drugs
meropenem
03
Conditions
Central nervous system infectionmeningitis
Beyond the preview
Go deeper on NCT02506686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02506686.